Sarah White, Assistant Director, has been a member of the QI Program since 2003. In her current role, she is responsible for strategic planning of the QI Program and collaboration with IRB, CCI, CRP and other groups involved in investigator and study staff training. Sarah provides training and guidance to investigators holding investigational product applications from the FDA (IND/IDE). Prior to joining the QI Program, Sarah worked in Regulatory Affairs and was responsible for FDA and international regulatory submissions for a drug delivery pharmaceutical company. Before gaining industry experience, Sarah was a clinical research coordinator at MGH. Sarah received her BA in Biology from Dartmouth College and her Masters in Public Health from Boston University. She earned the Regulatory Affairs Certification (RAC) designation in 2002 and the Council for Certification for IRB Professionals (CIP) in 2009.